What is the risk of suicidal ideation or behavior in patients taking bimekizumab?
Featuring April Armstrong, MD, MPH | Co-Director |

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

| Published January 01, 2024
Loading...
Loading...
Loading...
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved